The study of hepatitis C virus (HCV) genotypes/subtypes, quasispecies and recombinants obtained by virus genome sequencing are important for epidemiological studies, to trace the source of infection, for devel...
Volume 14 Supplement 5
Proceedings of the Third Workshop of the HCV Study Group in the Calabria Region: Results from the South Italian Network for Rational Guidelines and International Epidemiology (SINERGIE) Project
Edited by Giampiero Carosi, Alfredo Focà and Carlo Torti
The workshop and publication of this proceedings supplement were funded by an unrestricted grant provided by Roche. Supplement Editor declarations: Carlo Torti has received grants for participation in Conferences or Advisory Boards from Gilead, ViiV, BMS. He also received research grants from BMS and Gilead. Carosi Giampiero and Alfredo Focà declare no competing interests. The peer review process for articles published in this supplement was overseen by the Supplement Editors in accordance with BioMed Central’s peer review guidelines for supplements.
Third Workshop of the HCV Study Group in the Calabria Region.
Catanzaro, Italy4 October 2013
Citation: BMC Infectious Diseases 2014 14(Suppl 5):S1
The epidemiological profile of HCV infection is evolving in Europe, as well as in Italy. We have previously showed genotype distributions and their dynamics in 2,153 HCV RNA positive patients living in Calabri...Citation: BMC Infectious Diseases 2014 14(Suppl 5):S2
Present, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antivirals
In Italy, anti-HCV drugs are provided free of charge by the National Health System. Since 2011, three drug regimens including a directly acting antiviral (DAA) are considered the gold standard for HCV treatmen...Citation: BMC Infectious Diseases 2014 14(Suppl 5):S3
Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV
HIV infection leads to a faster progression of liver disease in subjects infected with HCV, as compared with HCV mono-infected patients. Previous reports suggest that sustained virological response (SVR) rates...Citation: BMC Infectious Diseases 2014 14(Suppl 5):S4
Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?
Interleukin 27 (IL-27) has pleiotropic properties that can either limit or enhance immune responses. Recent studies revealed that single nucleotide polymorphisms (SNPs) of the IL-27 promoter region modulate th...Citation: BMC Infectious Diseases 2014 14(Suppl 5):S5
microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virus
Epidemiological evidence links Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) to B-cell non-Hodgkin lymphoma (B-NHL). These B-NHLs, particularly those associated with HCV, may represent a distinct sub-gro...Citation: BMC Infectious Diseases 2014 14(Suppl 5):S6
We present clinical cases, which underline some difficulties in diagnosis and treatment of hepatitis C virus (HCV) infection. Case report #1 shows a patient who avoided clinical follow-up for HCV until the dev...Citation: BMC Infectious Diseases 2014 14(Suppl 5):S7
Molecular diagnostics in the management of chronic hepatitis C: key considerations in the era of new antiviral therapies
Molecular tests that detect and/or quantify HCV RNA are important in the diagnosis and management of patients with chronic hepatitis C (CHC) undergoing anti-viral therapy. The primary goal of anti-HCV therapy ...Citation: BMC Infectious Diseases 2014 14(Suppl 5):S8
Annual Journal Metrics
2022 Citation Impact
3.7 - 2-year Impact Factor
3.6 - 5-year Impact Factor
1.283 - SNIP (Source Normalized Impact per Paper)
1.055 - SJR (SCImago Journal Rank)
21 days submission to first editorial decision for all manuscripts (Median)
154 days submission to accept (Median)
74,440 Altmetric mentions
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication